{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2022"],"condition":["Breast cancer, colorectal cancer"],"disease":["Breast Cancer, Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/37173"],"location":["China"],"study_start_month":["3"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Effect of rice bran arabinoxylan (MGN-3) on immune function in patients with breast and colorectal cancer: a prospective, open-label, single-arm clinical trial","description":"Interventions: Experimental group:MGN-3\nPrimary outcome(s): Change from baseline in patient NK cell levels\nStudy Design: Single arm","dates":{"creation":"2022-03-15"},"accession":"37173","cross_references":{"Chinese Clinical Trial Register":["ChiCTR2200056886"]}}